HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomás Sobrino Selected Research

Ischemic Stroke

6/2022Surrogate biomarkers of outcome for wake-up ischemic stroke.
2/2022Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke.
1/2022The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction.
1/2022Involvement of Ceramide Metabolism in Cerebral Ischemia.
1/2022Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers.
8/2021Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial.
7/2021Characterization of a Temporal Profile of Biomarkers as an Index for Ischemic Stroke Onset Definition.
1/2021Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage.
1/2021sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies.
1/2021Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomás Sobrino Research Topics

Disease

52Stroke (Strokes)
06/2022 - 01/2006
50Ischemic Stroke
06/2022 - 01/2007
24Inflammation (Inflammations)
06/2022 - 01/2006
18Brain Ischemia (Cerebral Ischemia)
01/2022 - 06/2007
12Infarction (Infarctions)
01/2019 - 01/2006
10Periodontitis
06/2022 - 01/2019
9Migraine Disorders (Migraine)
03/2020 - 05/2007
9Ischemia
10/2018 - 01/2006
8Hematoma
07/2021 - 01/2007
8Cerebral Hemorrhage
12/2020 - 12/2009
6Brain Injuries (Brain Injury)
01/2018 - 01/2008
5Keratoconus
02/2021 - 10/2010
4Obesity
02/2022 - 01/2019
4Leukoaraiosis
01/2022 - 10/2009
4Necrosis
12/2021 - 01/2016
3Body Weight (Weight, Body)
02/2022 - 01/2019
3Lacunar Stroke
01/2019 - 01/2006
3Embolic Stroke
01/2019 - 07/2013
3Edema (Dropsy)
01/2013 - 01/2007
3Brain Edema (Cerebral Edema)
12/2012 - 01/2007
2Cerebral Infarction
01/2021 - 01/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2020
2Hypothermia
01/2020 - 01/2016
2Atrial Fibrillation
01/2019 - 07/2013
2Hemorrhage
01/2018 - 06/2017
2Asphyxia (Suffocation)
01/2017 - 01/2016
2Transient Ischemic Attack
01/2017 - 08/2013
2Hemorrhagic Stroke
04/2010 - 01/2009
1Peri-Implantitis
10/2021
1Cognitive Dysfunction
03/2021
1Parkinson Disease (Parkinson's Disease)
01/2021

Drug/Important Bio-Agent (IBA)

25Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2006
19Glutamic Acid (Glutamate)FDA Link
06/2022 - 03/2006
17Interleukin-6 (Interleukin 6)IBA
06/2022 - 01/2006
11Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 01/2007
9Toll-Like Receptors (Toll-Like Receptor)IBA
06/2022 - 01/2009
8Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2006
8EnzymesIBA
01/2022 - 06/2011
8Oxaloacetic Acid (Oxalacetic Acid)IBA
01/2017 - 06/2011
7Neuroprotective AgentsIBA
01/2022 - 06/2008
7Transaminases (Aminotransferases)IBA
01/2017 - 06/2011
6Fibronectins (Fibronectin)IBA
06/2022 - 06/2007
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 06/2011
6IronIBA
08/2021 - 01/2007
6erucylphosphocholineIBA
04/2017 - 10/2007
5C-Reactive ProteinIBA
06/2022 - 01/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 12/2009
4Brain Natriuretic Peptide (Natrecor)FDA Link
06/2022 - 01/2009
4Interleukin-10 (Interleukin 10)IBA
10/2021 - 06/2013
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2020 - 05/2007
4Peptides (Polypeptides)IBA
01/2020 - 10/2009
3Therapeutic UsesIBA
01/2022 - 01/2017
3Biological ProductsIBA
01/2021 - 01/2008
3PTX3 proteinIBA
03/2020 - 01/2018
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 06/2007
3Amyloid beta-PeptidesIBA
01/2020 - 10/2009
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 12/2009
3Endothelin-1 (Endothelin 1)IBA
06/2015 - 07/2008
3NeuroserpinIBA
05/2011 - 02/2011
3Ferritins (Ferritin)IBA
04/2010 - 01/2007
2Vitamin DFDA LinkGeneric
06/2022 - 03/2021
2LigandsIBA
06/2022 - 06/2011
2InterleukinsIBA
02/2022 - 06/2011
2AdiponectinIBA
02/2022 - 01/2018
2LeptinIBA
02/2022 - 01/2018
2CeramidesIBA
01/2022 - 01/2021
2SphingolipidsIBA
01/2022 - 01/2021
2LipidsIBA
10/2021 - 01/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2021 - 10/2020
2Amyloid (Amyloid Fibrils)IBA
07/2021 - 01/2013
2tau Proteins (tau Protein)IBA
07/2021 - 01/2020
2Matrix Metalloproteinases (MMPs)IBA
07/2021 - 07/2020
2Type A Botulinum Toxins (Botox)FDA Link
01/2021 - 01/2020
2Pharmaceutical PreparationsIBA
07/2020 - 01/2018
2Calcitonin Gene-Related PeptideIBA
10/2019 - 07/2012
2Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2019 - 02/2011
2Collagenases (Collagenase)FDA Link
10/2018 - 07/2015
2Glucose (Dextrose)FDA LinkGeneric
10/2018 - 01/2006
2Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2017 - 01/2016
2Cytidine Diphosphate Choline (Citicoline)IBA
01/2013 - 07/2011
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2012 - 06/2008
2Excitatory Amino Acid AntagonistsIBA
02/2012 - 03/2006
24- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
07/2008 - 06/2007
1Fibrinogen (Factor I)FDA Link
06/2022
1Chaperonin 60IBA
06/2022
1Hormones (Hormone)IBA
02/2022
1fibroblast growth factor 21IBA
02/2022
1Drug CarriersIBA
01/2022
1Steroidogenic Factor 1IBA
10/2021
1AMP-Activated Protein KinasesIBA
10/2021
1CholesterolIBA
10/2021
1LDL CholesterolIBA
10/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2021
1Chelating AgentsIBA
08/2021
1AntioxidantsIBA
08/2021
1Deferoxamine (Desferal)FDA LinkGeneric
08/2021

Therapy/Procedure

24Therapeutics
06/2022 - 01/2006
4Thrombolytic Therapy
01/2021 - 01/2007
2Aftercare (After-Treatment)
06/2007 - 01/2007
1Intravenous Injections
10/2021